Volume 82, Issue 1, December 2025, Pages 1–7



Bharath Reddy1
1 Process Automation, Schneider Electric Inc, Lake Forest, CA, USA
Original language: English
Copyright © 2025 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
COVID-19 vaccination has been reported to have had some side effects or abnormalities. These abnormalities have been reported after 1 - 2 years after the first dosage. In this paper, we want to investigate if this is true in Indian Population using the Indian Health Authority (IHA) data from January 2022 to December 2022. From this database, we selected a sample data which is a portion of the people living in the great of city of New Delhi. All the sample data contained adults who are > 18 years of age and were either vaccinated or unvaccinated (Sample size n = 11,341,189). In the abnormalities, we particularly want to study if there are any changes to iron deficiency in women particularly as Indian women suffer from low Iron naturally. From the results we found out that the abnormalities after a 3-month period after the vaccination were higher than those in nonvaccinated patients. COVID-19 mRNA vaccine was associated with this new development of nutritional anaemia and aplastic anaemia which were detected in the sample study. The risk of other abnormalities like coagulation defects were also increased after the vaccination and there was also no other risks mRNA vaccine and other viral vector vaccine. We conclude that COVID-19 vaccination did increase the risk of anaemia furthermore than it was before. We find that, education, accessibility of more nutritional food and vitamin intake is the solution for the people suffering from anaemia due to vaccine administration.
Author Keywords: COVID-19, vaccine, abnormality, anaemia, coagulation.



Bharath Reddy1
1 Process Automation, Schneider Electric Inc, Lake Forest, CA, USA
Original language: English
Copyright © 2025 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
COVID-19 vaccination has been reported to have had some side effects or abnormalities. These abnormalities have been reported after 1 - 2 years after the first dosage. In this paper, we want to investigate if this is true in Indian Population using the Indian Health Authority (IHA) data from January 2022 to December 2022. From this database, we selected a sample data which is a portion of the people living in the great of city of New Delhi. All the sample data contained adults who are > 18 years of age and were either vaccinated or unvaccinated (Sample size n = 11,341,189). In the abnormalities, we particularly want to study if there are any changes to iron deficiency in women particularly as Indian women suffer from low Iron naturally. From the results we found out that the abnormalities after a 3-month period after the vaccination were higher than those in nonvaccinated patients. COVID-19 mRNA vaccine was associated with this new development of nutritional anaemia and aplastic anaemia which were detected in the sample study. The risk of other abnormalities like coagulation defects were also increased after the vaccination and there was also no other risks mRNA vaccine and other viral vector vaccine. We conclude that COVID-19 vaccination did increase the risk of anaemia furthermore than it was before. We find that, education, accessibility of more nutritional food and vitamin intake is the solution for the people suffering from anaemia due to vaccine administration.
Author Keywords: COVID-19, vaccine, abnormality, anaemia, coagulation.
How to Cite this Article
Bharath Reddy, “COVID-19 vaccination and abnormalities in indian population,” International Journal of Innovation and Scientific Research, vol. 82, no. 1, pp. 1–7, December 2025.